Clinical trial
STAR Trial (Siegel Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis)
NCT07278310 is registered in ClinicalTrials.gov with MiRus as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- STAR Trial (Siegel Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis)
- Lead sponsor
- MiRus
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- April 30, 2026
- Completion date
- April 30, 2028
- Enrollment
- 1,025 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aortic stenosis, symptomatic severe native aortic stenosis